Skip to main content

Table 1 General characteristics of HCC and HCV cases

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

 HCC patientsControlp value
Age (years)Mean ± SD55.7 ± 6.742.6 ± 7.4< 0.001*a
Range40–7625–57
SexMale36 (76.6%)36 (72.0%)0.605b
Female11 (23.4%)14 (28.0%)
  1. HCC hepatocellular carcinoma, HCV hepatitis C virus
  2. aStudent’s t test
  3. bChi-square test
  4. *Statistically significant at p < 0.05